“…To date, 21 RA serotypes with differences in virulence, both between and sometimes within a given serotype, have been identified, with less or no significant cross-protection among serotypes [11]. RA outbreaks have been documented in various countries, with the most commonly identified pathogenic isolates reported belonging to serotypes 1, 2, 3, 4, 5, and 15 [4,8,9,[12][13][14]. Treatment for RA infection is carried out using antibiotics, but recent reports have shown drug resistance to various antibiotics, highlighting the need to identify novel therapeutic strategies [12,14].…”